U.S. markets closed

InVivo Therapeutics Holdings Corp. (NVIV)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.1500-0.0500 (-4.17%)
At close: 4:00PM EST
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
As of Date: 2/27/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (5Y Monthly) 1.70
52-Week Change 3-79.13%
S&P500 52-Week Change 323.92%
52 Week High 36.3200
52 Week Low 30.5000
50-Day Moving Average 31.3370
200-Day Moving Average 31.0756

Share Statistics

Avg Vol (3 month) 36.03M
Avg Vol (10 day) 33.53M
Shares Outstanding 521.17M
Float 21.16M
% Held by Insiders 112.35%
% Held by Institutions 17.09%
Shares Short (Feb 11, 2021) 44.12M
Short Ratio (Feb 11, 2021) 40.53
Short % of Float (Feb 11, 2021) 419.70%
Short % of Shares Outstanding (Feb 11, 2021) 419.45%
Shares Short (prior month Jan 14, 2021) 41.55M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:30
Last Split Date 3Feb 11, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-55.67%
Return on Equity (ttm)-130.92%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-10.25M
Diluted EPS (ttm)-3.8220
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)7.9M
Total Cash Per Share (mrq)0.37
Total Debt (mrq)1.1M
Total Debt/Equity (mrq)14.05
Current Ratio (mrq)4.38
Book Value Per Share (mrq)1.60

Cash Flow Statement

Operating Cash Flow (ttm)-9.5M
Levered Free Cash Flow (ttm)-5.69M